[Pharmacotherapy in coronary artery disease].
With the exception of anticoagulant therapy this article reviews pharmacotherapy for patients with coronary artery disease based on indications, clinical trials and current guidelines. Mechanisms of action, contraindications, and interactions are reviewed in this article. Only an appropriate use of available drugs according to guidelines permits to achieve the best relation of benefit and risk.
Schoenenberger
Andreas W
AW
Geriatrische Abklärungsstation, Universitätsklinik für Allgemeine Innere Medizin, Inselspital, Bern.
Erne
Paul
P
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents